XOMA Royalty (XOMA) Cash & Equivalents (2010 - 2026)

XOMA Royalty's (XOMA) quarterly Cash & Equivalents came in at $85.6 million in Q1 2026, up 1367.76% year-on-year from $5.8 million in Q1 2025, and up 3.25% quarter-over-quarter from $82.9 million in Q4 2025.

XOMA Royalty (XOMA) Cash & Equivalents (2010 - 2026) Analysis & Trends

XOMA Royalty has disclosed Cash & Equivalents across 17 years of filings, most recently posting $85.6 million for Q1 2026.

  • Cash & Equivalents for Q1 2026 came in at $85.6 million, up 1367.76% year-over-year; the trailing twelve-month figure through Mar 2026 was $85.6 million (up 1367.76% YoY), and the FY2025 annual result was $82.9 million, up 822.94% from the prior year.
  • Cash & Equivalents came in at $85.6 million for Q1 2026 at XOMA Royalty, up from $82.9 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $153.3 million in Q4 2023 to a low of $4.0 million in Q3 2024.
  • The 5-year median for Cash & Equivalents is $33.5 million (2023), against an average of $57.6 million.
  • Across the five-year window, Cash & Equivalents plunged 95.72% in 2025 and soared 1367.76% in 2026, its largest moves.
  • XOMA Royalty's Cash & Equivalents stood at $30.3 million in 2022, then soared by 405.91% to $153.3 million in 2023, then slumped by 94.14% to $9.0 million in 2024, then surged by 822.94% to $82.9 million in 2025, then gained by 3.25% to $85.6 million in 2026.
  • The last three Cash & Equivalents figures came in at $85.6 million (Q1 2026), $82.9 million (Q4 2025), and $10.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 32.30 Mn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 1.91 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 286.70 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 2.77 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 18.44 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 5.49 Bn
9 Abivax 95.45 Bn 95.45 Bn - 558.94 Mn
10 XOMA Royalty 5.52 Mn -60.56 Mn - 85.60 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 85.60 Mn
Dec 31, 2025 82.91 Mn
Sep 30, 2025 10.18 Mn
Jun 30, 2025 6.99 Mn
Mar 31, 2025 5.83 Mn
Dec 31, 2024 8.98 Mn
Sep 30, 2024 4.02 Mn
Jun 30, 2024 143.90 Mn
Mar 31, 2024 136.23 Mn
Dec 31, 2023 153.29 Mn
Sep 30, 2023 33.47 Mn
Jun 30, 2023 31.40 Mn
Mar 31, 2023 44.30 Mn
Dec 31, 2022 30.30 Mn
Sep 30, 2022 30.20 Mn
Jun 30, 2022 83.18 Mn
Mar 31, 2022 87.80 Mn
Dec 31, 2021 93.33 Mn
Sep 30, 2021 68.76 Mn
Jun 30, 2021 78.95 Mn